Showing results (51-60 of 59) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Molecular Pharmacology|November 1, 1996
Rat 17 beta-hydroxysteroid dehydrogenase type IV is a novel peroxisome proliferator-inducible geneJ C Corton, C Bocos, E S Moreno, et al.Toxicological Sciences : an Official Journal of the Society of Toxicology|September 25, 1999
Effects of a thirteen-week inhalation exposure to ethyl tertiary butyl ether on fischer-344 rats and CD-1 miceM A Medinsky, D C Wolf, R C Cattley, et al.Carcinogenesis|February 6, 1999
Kupffer cell oxidant production is central to the mechanism of peroxisome proliferatorsM L Rose, C A Rivera, B U Bradford, et al.Cancer Chemotherapy and Pharmacology|January 1, 1993
Development of a model of melphalan-induced gastrointestinal toxicity in miceS Castellino, G B Elion, O W Griffith, et al.Journal of Veterinary Internal Medicine|March 31, 2015
Experimental transmission of Corynebacterium pseudotuberculosis biovar equi in horses by house fliesM Barba, A J Stewart, T Passler, et al.Cancer Research|March 1, 1989
Use of primary cultures of human hepatocytes in toxicology studiesB E Butterworth, T Smith-Oliver, L Earle, et al.Carcinogenesis|July 30, 1999
Altered bcl-2 family expression during non-genotoxic hepatocarcinogenesis in miceJ G Christensen, E H Romach, L N Healy, et al.Regulatory Toxicology and Pharmacology : RTP|June 18, 1998
Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans?R C Cattley, J DeLuca, C Elcombe, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2001
IL-18-binding protein protects against lipopolysaccharide- induced lethality and prevents the development of Fas/Fas ligand-mediated models of liver disease in miceR Faggioni, R C Cattley, J Guo, et al.Pageof 6